BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15077145)

  • 1. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential.
    Lin DY; Lai MZ; Ann DK; Shih HM
    J Biol Chem; 2003 May; 278(18):15958-65. PubMed ID: 12595526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L; Valencia A; Rojas AM
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.
    Pampin M; Simonin Y; Blondel B; Percherancier Y; Chelbi-Alix MK
    J Virol; 2006 Sep; 80(17):8582-92. PubMed ID: 16912307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML interaction with p53 and its role in apoptosis and replicative senescence.
    Pearson M; Pelicci PG
    Oncogene; 2001 Oct; 20(49):7250-6. PubMed ID: 11704853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently.
    Nefkens I; Negorev DG; Ishov AM; Michaelson JS; Yeh ET; Tanguay RM; Müller WE; Maul GG
    J Cell Sci; 2003 Feb; 116(Pt 3):513-24. PubMed ID: 12508112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
    Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
    Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses as hijackers of PML nuclear bodies.
    Möller A; Schmitz ML
    Arch Immunol Ther Exp (Warsz); 2003; 51(5):295-300. PubMed ID: 14626429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
    Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
    J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deconstructing PML-induced premature senescence.
    Bischof O; Kirsh O; Pearson M; Itahana K; Pelicci PG; Dejean A
    EMBO J; 2002 Jul; 21(13):3358-69. PubMed ID: 12093737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.